Single-dose daclizumab induction therapy in patients with liver transplantation

Table 1 General data in two groups

	Induction group (n = 23)	Non-induction group (n = 31)
Average age(yr)	39.17(19-68)	38.76(11-57)
Male/female	21/2	23/8
Indication with
Liver cirrhosis	15	18
Liver cancer	6	6
Other	2	7
UNOS classification
Grade I	5	10
Grade II	18	21
Child classification
Grade A	4	9
Grade B	2	0
Grade C	17	22
Blood type
ABO-identical	14	23
ABO-compatible	9	8

Table 2 Postoperative complications in two groups

	Induction (n = 23)	Non-induction (n = 31)
Intraperitoneal bleeding	1	3
Ascite infection	0	1
Stress ulcer bleeding	1	3
Stress ulcer perforation	0	1
Pulmonary infection	5	11
Heart failure	1	3
Biliary leakage	1	3
Chronic oral ulcer	2	3
Bowel fungal infection	1	2
Intracerebral bleeding	1	3
Total	13	32